Friday, August 8, 2025

Coforge wins $1.56 billion, 13-year deal with Sabre to advance AI-enabled travel solutions

Date:

IT solutions company Coforge Ltd on Tuesday (March 4) said it has signed a $1.56 billion, multi-year agreement with Sabre Corporation, a leading global travel technology company, to strengthen their long-standing partnership and accelerate Sabre’s product roadmap.Under this 13-year contract, Coforge will play a key role in enhancing product delivery and developing AI-enabled solutions, reinforcing Sabre’s commitment to innovation, speed, and scale. The collaboration aims to drive advancements in travel technology, leveraging AI to optimise solutions for the industry.

Also Read: Coforge Q3 Results: Stock surges 10% after a strong quarter, acquisition, dividend payout
Kurt Ekert, CEO and President of Sabre, said, “Laser focus, ruthless prioritization and key technology investments have positioned us to intensify innovation and reinforce our pursuit of being the most valued global technology platform in travel.Sabre is in an advantaged position to pioneer, build, and deploy the next generation of solutions alongside our continuously expanding travel marketplace, and we look forward to Coforge’s partnership in expediting the process.”

Sabre’s future-forward technology and disruptive approach to the market, coupled with Coforge’s scale and expertise, seeks to become a driving force in modernizing the travel industry as a whole – leading a new standard for the pace of change.

Also Read: Coforge shares recover from lows post commentary; analysts raise target by up to 25%

Shares of Coforge Ltd ended at ₹7,228.00, down by ₹128.50, or 1.75%, on the BSE.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Asian stocks rise after dip-buyers fuel US rally

Asian stocks rose at the open after a wave...

PhonePe SBI Card SELECT BLACK: Reward rates, fees, and benefits explained

पिछले कुछ वर्षों में, कुछ बैंकों ने उपयोगिता बिल...

Four Pharma stocks that should be on your radar ahead of Tuesday’s trade

Shares of four Indian drugmakers will be in focus...

Market volatility continues: Should investors reconsider continuing their mutual fund SIPs?

Mutual Funds: Stock markets in India have been under...